XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net loss $ (19,243) $ (31,380)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 190 158
Stock-based compensation 4,884 3,404
Non-cash lease expense 144 232
Accretion of discount on marketable debt securities (607)  
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 486 (232)
Other assets, noncurrent   (340)
Accounts payable (753) (9,896)
Accrued expenses and other current liabilities (13,273) 10,540
Operating lease liabilities 1,331 (165)
Net cash used in operating activities (26,841) (27,679)
Investing activities    
Purchase of marketable debt securities (94,987)  
Purchase of property and equipment (4,406) (146)
Net cash used in investing activities (99,393) (146)
Financing activities    
Proceeds from the exercise of stock options   176
Net cash provided by financing activities   176
Net (decrease) increase in cash, cash equivalents, and restricted cash (126,234) (27,649)
Cash, cash equivalents and restricted cash at beginning of year 180,765 276,316
Cash, cash equivalents and restricted cash at end of period 54,531 248,667
Supplemental cash flow information:    
Cash received for interest 915  
Cash paid for taxes 20  
Noncash investing and financing activities:    
Property and equipment in accounts payable and accrued expenses 2,261  
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 53,059 247,087
Restricted cash 1,472 1,580
Total cash, cash equivalents and restricted cash shown in the statement of cash flows $ 54,531 $ 248,667